CN108371684A - 一种经骨通透皮止痛膏及制备方法 - Google Patents
一种经骨通透皮止痛膏及制备方法 Download PDFInfo
- Publication number
- CN108371684A CN108371684A CN201810417875.XA CN201810417875A CN108371684A CN 108371684 A CN108371684 A CN 108371684A CN 201810417875 A CN201810417875 A CN 201810417875A CN 108371684 A CN108371684 A CN 108371684A
- Authority
- CN
- China
- Prior art keywords
- parts
- disease
- pain relieving
- bone
- collaterals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 43
- 230000036407 pain Effects 0.000 title claims abstract description 43
- 239000002674 ointment Substances 0.000 title claims abstract description 28
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 21
- 230000000149 penetrating effect Effects 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 40
- 229940079593 drug Drugs 0.000 claims abstract description 28
- 206010047700 Vomiting Diseases 0.000 claims abstract description 14
- 230000008673 vomiting Effects 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 12
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 12
- 241000522254 Cassia Species 0.000 claims abstract description 12
- 241000258920 Chilopoda Species 0.000 claims abstract description 12
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 12
- 241000522620 Scorpio Species 0.000 claims abstract description 12
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 12
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 12
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 12
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940116229 borneol Drugs 0.000 claims abstract description 12
- 229930008380 camphor Natural products 0.000 claims abstract description 12
- 229960000846 camphor Drugs 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000009136 dragon's blood Substances 0.000 claims abstract description 12
- 239000009490 scorpio Substances 0.000 claims abstract description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 11
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 11
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 claims abstract description 11
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000227129 Aconitum Species 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 230000001351 cycling effect Effects 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 37
- 201000010099 disease Diseases 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 206010010904 Convulsion Diseases 0.000 abstract description 8
- 230000036461 convulsion Effects 0.000 abstract description 8
- 208000033952 Paralysis flaccid Diseases 0.000 abstract description 6
- 208000028331 flaccid paralysis Diseases 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 206010067484 Adverse reaction Diseases 0.000 abstract description 3
- 230000006838 adverse reaction Effects 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 210000003414 extremity Anatomy 0.000 description 17
- 238000011282 treatment Methods 0.000 description 8
- 230000003902 lesion Effects 0.000 description 6
- 239000011505 plaster Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 206010044565 Tremor Diseases 0.000 description 3
- 229940090044 injection Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000002513 Flank pain Diseases 0.000 description 2
- 206010064950 Head titubation Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000010930 hyperostosis Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940025300 lidocaine injection Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229940048101 prednisolone 25 mg Drugs 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种经骨通透皮止痛膏及制备方法,是利用人工麝香;全蝎;蜈蚣;地龙;马钱子;川乌;红花;血竭;土鳖虫;田七;当归;川穹;丁香份;肉桂;北细辛;樟脑;冰片;甘草等天然药物提精制而成;具有通经活络,活血散瘀、消炎止痛、祛风御寒之功效,有效解决经络各种痹症、痉症、痿症、颤症、腰腿等经络疾病;还具有用药方便,无毒副作用及不良反应,见效快、标本兼治的特点。
Description
技术领域
本发明涉及一种经骨通透皮止痛膏,用于治疗经络疾病的痹症、痉症、痿症、颤症、腰痛等经络疾病症,属于中医制药技术领域。
背景技术
肢体经络痛症是由于外感或内伤等因素,导致机体失养或气血瘀滞等病痛,出现肢体经络相关症状,甚或肢体功能障碍,结构失常的一类疾病,其临床特征多为肢体疼痛、麻木、震颤、肢体不用或屈伸不利。病因尚不明确,与寒冷、气候潮湿、药物、饮食有关,与现代科技电脑、手机的应用后引起的久坐、低头族等习惯有关,与以关节为主的多系统炎症性自身免疫性疾病有关。
根据目前针对经络的疾病临床用药一般都以西药或打针封闭等治疗,这样的用药只能解决较短时间的痛苦,但停药后又出现反复发作的缺点,为此有必要探讨一种新的用药补充途径。
透皮给药系统己经在药学上得到广泛应用,如治疗心绞痛、运动病痛、高血压等都采用了局部透皮给药。透皮给药可以使药物的有效成分直接从皮肤渗透进皮肤,进入血液循环直达病灶,根除疾病的作用。根据透皮的药用原理,经骨通透皮止痛膏作用于肌表,使药物的有效成分直达病灶。配以中药提取之精华,因此可透入皮肤产生开结行滞,活血化淤,消炎止痛,祛风御寒等 ;此外,药物穿通皮肤及黏膜后,经过血液循环达到全身给药,可以调节肌体功能,提高人体免疫力 ;本发明的经骨通透皮止痛膏是利用人工麝香;全蝎;蜈蚣;地龙;马钱子;川乌;红花;血竭;土鳖虫;田七;当归;川穹;丁香份;肉桂;北细辛;樟脑;冰片;甘草等天然药物提精制而成。本经骨通透皮止痛膏具有通经活络,活血散瘀、消炎止痛、祛风御寒之功效,有效解决经络各种痹症、痉症、痿症、颤症、腰腿等经络疾病。还具有用药方便,无毒副作用及不良反应,见效快、标本兼治的特点。
发明内容
本发明目的是提供一种经络通透皮止痛膏,是一种针对经络疾病的痹症、痉症、痿症、颤症、腰痛等经络疾病症,临床治疗效果显著的透皮止痛膏。经络通透皮止痛膏具有直接透皮供给药物活性物质、促进药物血液循环直达病灶,有效解决各种经络疾病的痹症、痉症、痿症、颤症、腰痛等经络疾病,是一种用药方便、无毒副作用及不良反应、见效快、标本兼治而且对环境无任何污染的绿色安全营养透皮止痛膏。为达到上述目的,本发明采用以下技术措施,依据药用植物提取物能促进细胞转化和增殖,抗菌、抗病毒、抗氧化功效。
其特征在于其特征在于是由以下原料重量份数比制成的:
本发明所述的一种经骨通透皮止痛膏,其特征在于是由以下原料重量份数比制成的:
人工麝香10-15份;全蝎10-15份;蜈蚣11-15份;地龙10-15份;马钱子30-35份;川乌25-30份;红花32-37份;血竭27-32份;土鳖虫30-35份;田七25-30;当归25-30份;川穹21-26份;丁香11-16份;肉桂10-20份;北细辛25-30份;樟脑8-10份;冰片5-12份;甘草20-30份。
所述的一种经骨通透皮止痛膏,其优选配比为:
人工麝香15份;全蝎15份;蜈蚣15份;地龙15份;马钱子35份;川乌30份;红花37份;血竭32份;土鳖虫35份;田七30份;当归30份;川穹26份;丁香16份;肉桂20份;北细辛30份;樟脑10份;冰片12份;甘草30份。
所述的一种陈氏透皮止痛膏的制备方法,其特征在于:
(1)将上述物料按比例秤取,采用现有的循环热蒸馏方法提取各个药物中有效成分;
(2)将提取的药物有效成分混合均匀溶解于成膜材料中而制成的固体制剂;成膜材料是由高分子材料,如羧甲基纤维素钠,聚乙烯醇、聚丙烯酸纳等经加热溶解制成膏贴,上软膜存放。
本发明方解:
方中人工麝香,味辛、性湿。功效通窍、开经络、透肌骨;全蝎,辛平,功效穿筋透节,祛风止痉;蜈蚣,味辛、性湿。开窍通络、湿经止痛;地龙,性檀走窜,具有通经活络,屈伸不利之功效;四药协同有通关开窍,又有投肌活络之功能共为君药。马钱子、川乌、红红、血竭、土鳖虫、田七功效均有活血散瘀,舒筋活络相仿功效。配于当归、川穹、丁香、肉桂、北细辛,辛湿之品善行气、湿经络,列药归经助诸药活血通络,消肿止痛。而方中马钱子、川乌有毒之品是取其验药开泄以毒攻毒之效,协同君药以通经络治疗痹症之顽疾。十味药以其辛热而通塞,以其香窜而开窍,以上俱为臣药。樟脑、冰片、薄荷脑三者功效相仿,皆能行气通关,走窜经络,又能列药透肌,直达病灶,以使经络气血畅行,疼痛随之而消,三药合为佐。甘草本方用其甘平之性以调和诸药相协,解百毒、缓止痛为使药。本方中的马钱子、川乌均为有毒之品因此配于甘草可缓解其药中的毒性,以达到用药安全的目的。综合本方,不仅通经络行气血、又解气血之郁结,活血而不耗血,祛瘀而生新,合而用之可作为通治一切经络痹症之气滞血瘀之良方。
【用法用量】:外用,敷贴患处,每二天一贴,10~30g/贴。
【适应症】:用于肢体经络病症的痹症、痉症、痿症、颤症、腰痛等症状,肢体关节,肌肉疼痛酸楚,屈伸不利,项背强直,四肢抽搐,肢体软弱无力,手足麻木,肢体颤动,头摇不止,腰部疼痛,转侧不利等经络病症见上述症候者。
主要功效:开窍通经,活血散瘀,消肿止痛。
疗效证明:
1、类风湿关节炎:63例类风湿关节炎患者(所有病例有受累关节炎疼痛、肿胀及功能下降)按抽签法随机分为试验组(n=40)和对照组(n=23)。试验组采用经骨通透皮止痛膏,每两天一贴患部及穴位敷贴。对照组采用消炎痛片(吲哚美辛)75mg/d,3次餐后服用,雷公藤多苷片60mg/d,3次口服。6周为一个疗程。结果显示试验组总有效率为(93.6%)是对照组总有效率(62.4%)的1.5倍。(P<0.05);试验组主要症状,休症(最僵时间,压痛指数,肿胀指数,功能指数,双手握力,20m步行时间)改善及主要实验室指标(血沉,类风湿因子)变化均优于对照组。(P<0.01或0.05);随访半年,试验组复发率(17.4%,4/23)低于对照组复发率(61%,3/13)。(P<0.05)
2、神经根型颈椎病:70例神经根型颈椎病患者,随机分为试验组(n=38)和对照组(n=32)。试验组采用经骨通透皮止痛膏,敷贴于第3-6颈椎棘突两旁和疼痛部位,每两天一贴。对照组采用中成药颈复康颗粒,口服每天2次 ,每次2包。两组均10天为一个疗程,治疗3个疗程。结果显示试验组总有效率为(98.6%)是对照组总有效率(72.6%)的1.4倍。(P<0.05)
3、坐骨神经痛:(风寒湿痹症)84例患者随机分为试验组(n=54)和对照组(n=30)。试验组给与经骨通透皮止痛膏,敷于痛处及穴位。穴位取肾俞,环跳,承扶,委中,阳陵泉,阿是穴。将上述6个穴位分为3组,每二天用1组。对照组给与西药(注射用泼尼松龙25mg,维生素B1注射液100mg,维生素B12注射液250mg,利多卡因注射液50mg混合均匀)于同穴位处封闭,每周2次,两组均治疗3-9周。结果显示试验组总有效率(98.3%)略高于对照组总有效率(93.2%)。(P<0.05)
本发明的积极效果在于:是一种具有开窍通经,活血散瘀,消肿止痛的纯中药制剂,用于肢体经络病症的痹症、痉症、痿症、颤症、腰痛引起的肢体关节、肌肉疼痛酸楚,屈伸不利,项背强直,四肢抽搐,肢体软弱无力,手足麻木,肢体颤动,头摇不止,腰部疼痛,转侧不利等经络病症见上述症候者。本发明的中药制剂按照中医辩证论治的理论科学组方,由人工麝香;全蝎;蜈蚣;地龙;马钱子;川乌;红花;血竭;土鳖虫;田七;当归;川穹;丁香份;肉桂;北细辛;樟脑;冰片;甘草十八种中药组成,且具有法定标准。方中的人工麝香;全蝎;蜈蚣;地龙;通经开窍,透肌骨散瘀血,配以马钱子;川乌;红花;血竭;土鳖虫;田七;当归;川穹;丁香份;肉桂;北细辛;樟脑;冰片;甘草增强主药痛经止痛、活血散瘀,肿块消除,病痛自愈。
具体实施方式
实施例1、
一种经骨通透皮止痛膏,其添加物料及其重量比是:人工麝香10g;全蝎10 g;蜈蚣11g;地龙10g;马钱子30 g;川乌25g;红花32 g;血竭27 g;土鳖虫30g;田七25g;当归25g;川穹21g;丁香11g;肉桂10g;北细辛25g;樟脑8g;冰片5g;甘草20g;纯正香油50g。将上述物料按比例秤取,采用现有的循环热蒸馏方法提取各个药物中有效成分;将提取的药物有效成分混合均匀溶解于成膜材料中而制成的固体制剂;成膜材料是由高分子材料,如羧甲基纤维素钠,聚乙烯醇、聚丙烯酸纳等经加热溶解制成膏贴,上软膜存放。膏药从软膜取下,直敷于病灶部位,敷2天,第3天取下再敷新膏药。
经广西省南宁市中医院对130名颈椎病、骨质增生症患者使用,其中113人取得了本发明所述效果。其中典型病例:广西省南宁市博大医院中医住院部,梁某,46岁,2017年经诊断为膝关节增生性关节炎,肿胀,疼痛,功能活动受阻。X线拍片,胫骨踝间刺突变尖,骶骨上下极增生变尖,关节间隙变窄,住院治疗2月,病症未改善,后经人介绍使用本发明的药膏15帖,各种症状消除,已经出院至今未见复发。
实施例2、
一种经骨通透皮止痛膏,其添加物料及其重量比是:人工麝香15g;全蝎15g;蜈蚣15g;地龙15g;马钱子35g;川乌30g;红花37g;血竭32g;土鳖虫35g;田七30g;当归30g;川穹26g;丁香16g;肉桂20g;北细辛30g;樟脑10g;冰片12g;甘草30g;纯正香油56g。将上述物料按比例秤取,采用现有的循环热蒸馏方法提取各个药物中有效成分;将提取的药物有效成分混合均匀溶解于成膜材料中而制成的固体制剂;成膜材料是由高分子材料,如羧甲基纤维素钠,聚乙烯醇、聚丙烯酸纳等经加热溶解制成膏贴,上软膜存放。膏药从软膜取下,直敷于病灶部位,敷2天,第3天取下再敷新膏药。
经广西省南宁市博大医院对170名腰间盘突出、肩周炎症患者使用,其中155人取得了本发明所述效果。其中典型病例:朱某,女,56岁,2015年因左肩部受凉,而疼痛至活动不利。到医院治疗无明显缓解,局部压痛明显,行动不便,经医院诊断为肩周炎。治疗采用本发明实施例1制备的经骨通透皮止痛膏敷贴7天使用药膏3贴,症状全部消除。
实施例3、
一种经骨通透皮止痛膏,其添加物料及其重量比是:人工麝香13g;全蝎14g;蜈蚣12g;地龙12g;马钱子32g;川乌28g;红花35g;血竭29g;土鳖虫32g;田七28g;当归28g;川穹24g;丁香15g;肉桂15g;北细辛26g;樟脑9g;冰片10g;甘草25g;纯正香油50g。将上述物料按比例秤取,采用现有的循环热蒸馏方法提取各个药物中有效成分;将提取的药物有效成分混合均匀溶解于成膜材料中而制成的固体制剂;成膜材料是由高分子材料,如羧甲基纤维素钠,聚乙烯醇、聚丙烯酸纳等经加热溶解制成膏贴,上软膜存放。膏药从软膜取下,直敷于病灶部位,敷2天,第3天取下再敷新膏药。
经广西省南宁市人民医院对245名关节炎症患者使用,其中223人取得了本发明所述效果。其中典型病例:周某某,女,59岁,南宁市西乡矿区退休人员。2016年住院,主因腰痛8年,近期病情加重。患者8年前无明显诱因出现腰背部疼痛,反复到医院用外用药物进行对症治疗,病症未见明显改善。经医院检查腰椎生理曲度变直,诊断为腰椎退行性骨关节病。使用筋骨通透皮止痛膏敷贴30天,1个疗程用药膏15帖。行走恢复正常,至今未复发。
Claims (3)
1.一种经骨通透皮止痛膏,其特征在于是由以下原料重量份数比制成的:
人工麝香10-15份;全蝎10-15份;蜈蚣11-15份;地龙10-15份;马钱子30-35份;川乌25-30份;红花32-37份;血竭27-32份;土鳖虫30-35份;田七25-30;当归25-30份;川穹21-26份;丁香11-16份;肉桂10-20份;北细辛25-30份;樟脑8-10份;冰片5-12份;甘草20-30份。
2.如权利要求1所述的一种经骨通透皮止痛膏,其优选配比为:
人工麝香15份;全蝎15份;蜈蚣15份;地龙15份;马钱子35份;川乌30份;红花37份;血竭32份;土鳖虫35份;田七30份;当归30份;川穹26份;丁香16份;肉桂20份;北细辛30份;樟脑10份;冰片12份;甘草30份。
3.如权利要求1或2所述的一种陈氏透皮止痛膏的制备方法,其特征在于:
(1)将上述物料按比例秤取,采用现有的循环热蒸馏方法提取各个药物中有效成分;
(2)将提取的药物有效成分混合均匀溶解于成膜材料中而制成的固体制剂;成膜材料是由高分子材料,如羧甲基纤维素钠,聚乙烯醇、聚丙烯酸纳等经加热溶解制成膏贴,上软膜存放。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810417875.XA CN108371684A (zh) | 2018-05-04 | 2018-05-04 | 一种经骨通透皮止痛膏及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810417875.XA CN108371684A (zh) | 2018-05-04 | 2018-05-04 | 一种经骨通透皮止痛膏及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108371684A true CN108371684A (zh) | 2018-08-07 |
Family
ID=63033230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810417875.XA Pending CN108371684A (zh) | 2018-05-04 | 2018-05-04 | 一种经骨通透皮止痛膏及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108371684A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109568542A (zh) * | 2018-12-25 | 2019-04-05 | 倪涌济 | 草本麝香抑菌液 |
| CN112451943A (zh) * | 2019-08-20 | 2021-03-09 | 付英杰 | 一种多功效保健桩 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101693072A (zh) * | 2009-09-19 | 2010-04-14 | 吴秀侠 | 治疗颈椎、腰椎病的中药组方 |
| CN102579929A (zh) * | 2012-03-02 | 2012-07-18 | 姚少文 | 痹通止痛膏及其制备方法 |
| CN103463348B (zh) * | 2013-08-15 | 2015-09-09 | 孙金堂 | 一种骨科用止痛药膏 |
| CN105056099A (zh) * | 2015-05-18 | 2015-11-18 | 黄秋 | 一种治疗腰痛、腰椎骨质增生的药膏配方及制作方法 |
| CN107158297A (zh) * | 2017-07-01 | 2017-09-15 | 河南中医药大学 | 一种治疗骨科疼痛的中药膏及其制备方法 |
-
2018
- 2018-05-04 CN CN201810417875.XA patent/CN108371684A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101693072A (zh) * | 2009-09-19 | 2010-04-14 | 吴秀侠 | 治疗颈椎、腰椎病的中药组方 |
| CN102579929A (zh) * | 2012-03-02 | 2012-07-18 | 姚少文 | 痹通止痛膏及其制备方法 |
| CN103463348B (zh) * | 2013-08-15 | 2015-09-09 | 孙金堂 | 一种骨科用止痛药膏 |
| CN105056099A (zh) * | 2015-05-18 | 2015-11-18 | 黄秋 | 一种治疗腰痛、腰椎骨质增生的药膏配方及制作方法 |
| CN107158297A (zh) * | 2017-07-01 | 2017-09-15 | 河南中医药大学 | 一种治疗骨科疼痛的中药膏及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 孟胜男: "《药剂学 在线学习版》", 31 January 2016, 中国医药科技出版社 * |
| 王恩光: "《中国现代医学论文选》", 31 December 2005, 中医古籍出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109568542A (zh) * | 2018-12-25 | 2019-04-05 | 倪涌济 | 草本麝香抑菌液 |
| CN112451943A (zh) * | 2019-08-20 | 2021-03-09 | 付英杰 | 一种多功效保健桩 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988657B (zh) | 一种治疗骨折及跌打损伤的膏药及其制备方法 | |
| CN103599494B (zh) | 一种治疗颈椎病的外用中药 | |
| CN102258658B (zh) | 活血止痛膏 | |
| CN106421663A (zh) | 一种治疗风湿骨病的药物组合物及其制备方法 | |
| CN102614422A (zh) | 一种治疗痛风性急性关节炎的中药汤剂 | |
| CN110038075A (zh) | 一种热敷药物组合物及其制备方法 | |
| CN103393862B (zh) | 一种治疗腰腿痛的中药组合物 | |
| WO2012100754A1 (zh) | 一种治疗刀伤、烧伤及多种创伤中药组合物 | |
| CN108371684A (zh) | 一种经骨通透皮止痛膏及制备方法 | |
| CN103251865B (zh) | 一种治疗腹泻的中药组合物 | |
| CN110946903B (zh) | 用于防治系统性硬化病的中药组合物及其应用 | |
| CN104000890A (zh) | 调和肝脾、祛风除湿、养血止痹痛的中药 | |
| CN103893442A (zh) | 一种治疗风湿性关节炎的中药药剂及其制备方法 | |
| CN101002848B (zh) | 治疗复发性痛风的药物及其制备方法 | |
| CN103393813B (zh) | 治疗烧伤烫伤兼治化脓性感染、开放性外伤的纯中药制剂 | |
| CN101708292B (zh) | 一种治疗风湿、类风湿的中药 | |
| CN104435577A (zh) | 一种治疗腰椎间盘突出的中药膏药 | |
| CN104547936A (zh) | 一种治疗血液透析患者血管通路局部硬结的中药 | |
| CN104399055A (zh) | 一种治疗肩周炎的中药组合物 | |
| CN103585589B (zh) | 一种治疗慢性类风湿性关节炎的药物 | |
| CN115105580A (zh) | 一种外用消肿镇痛的含神经酸的中药组合物及制备方法 | |
| CN103007050B (zh) | 一种拔毒用外用中药 | |
| CN105561272A (zh) | 一种用于缓解雷诺病的中药制剂及其制备方法 | |
| CN104958735A (zh) | 一种治疗风湿性关节炎的中药 | |
| CN104644841B (zh) | 一种治疗颈肩腰腿痛的哈萨克药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180807 |
|
| WD01 | Invention patent application deemed withdrawn after publication |